Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season

被引:111
作者
Belongia, Edward A. [1 ]
Sundaram, Maria E. [1 ]
McClure, David L. [1 ]
Meece, Jennifer K. [1 ]
Ferdinands, Jill [2 ,3 ]
VanWormer, Jeffrey J. [1 ]
机构
[1] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA
[2] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA
[3] Battelle Mem Inst, Atlanta, GA USA
关键词
Influenza; Influenza vaccine; Immunity; Vaccine effectiveness; EFFICACY; ANTIBODY;
D O I
10.1016/j.vaccine.2014.06.052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Recent studies have suggested that vaccine-induced protection against influenza may decline within one season. We reanalyzed data from a study of influenza vaccine effectiveness to determine if time since vaccination was an independent predictor of influenza A (H3N2). Methods: Patients with acute respiratory illness were actively recruited during the 2007-2008 season. Respiratory swabs were tested for influenza, and vaccination dates were determined by a validated immunization registry. The association between influenza RT-PCR result and vaccination interval (days) was examined using multivariable logistic regression, adjusting for calendar time, age and other confounders. Results: There were 629 vaccinated participants, including 177 influenza A (H3N2) cases and 452 test negative controls. The mean (SD) interval from vaccination to illness onset was 101.7 (25.9) days for influenza cases and 93.0 (29.9) days for controls. There was a significant association between vaccination interval and influenza result in the main effects model. The adjusted odds ratio (a0R) for influenza was 1.12 (CI 1.01, 1.26) for every 14 day increase in the vaccination interval. Age modified the association between vaccination interval and influenza (p = 0.005 for interaction). Influenza was associated with increasing vaccination interval in young children and older adults, but not in adolescents or non-elderly adults. Similar results were found when calendar week of vaccine receipt was assessed as the primary exposure variable. Conclusions: Identification of influenza A (H3N2) was associated with increasing time since vaccination among young children and older adults during a single influenza season. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [31] Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease
    Benoit, Anne
    Beran, Jiri
    Devaster, Jeanne-Marie
    Esen, Meral
    Launay, Odile
    Leroux-Roels, Geert
    McElhaney, Janet E.
    Oostvogels, Lidia
    van Essen, Gerrit A.
    Gaglani, Manjusha
    Jackson, Lisa A.
    Vesikari, Timo
    Legrand, Catherine
    Tibaldi, Fabian
    Innis, Bruce L.
    Dewe, Walthere
    OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (02):
  • [32] Distinct molecular evolution of influenza H3N2 strains in the 2016/17 season and its implications for vaccine effectiveness
    Kim, Jin Il
    Park, Sehee
    Chu, Hyuk
    Lee, Ilseob
    Bae, Joon-Yong
    Yoo, Kirim
    Kim, Juwon
    Lee, Joo-Yeon
    Lee, Namju
    Kim, Miseon
    Kim, Jun-Sub
    Hong, Kyung Wook
    Jun, Kyung Ran
    Lee, Jeong Nyeo
    Kim, Kisoon
    Park, Man-Seong
    MOLECULAR PHYLOGENETICS AND EVOLUTION, 2019, 131 : 29 - 34
  • [33] Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses
    Duan, Wei
    Zhang, Li
    Wu, Shuangsheng
    Ma, Chunna
    Sun, Ying
    Zhang, Man
    Zhang, Yi
    Zhang, Xingxing
    Wang, Quanyi
    Yang, Peng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1031 - 1034
  • [34] Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re
    Song, Xiaoming
    Chen, Jian
    Sakwiwatkul, Kedsirin
    Li, Ruili
    Hu, Songhua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (03) : 351 - 356
  • [35] Evaluation of Influenza Vaccine Effectiveness Among Young Children Receiving Consecutive Versus Nonconsecutive Vaccination During Influenza A(H3N2)-Predominant Seasons
    Rao, Suchitra
    Moss, Angela
    Lamb, Molly M.
    Asturias, Edwin J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021, 10 (03) : 359 - 362
  • [36] Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents
    Munoz, Flor M.
    Anderson, Evan J.
    Bernstein, David, I
    Harrison, Christopher J.
    Pahud, Barbara
    Anderson, Edwin
    Creech, C. Buddy
    Berry, Andrea A.
    Kotloff, Karen L.
    Walter, Emmanuel B.
    Atmar, Robert L.
    Bellamy, Abbie R.
    Chang, Soju
    Keitel, Wendy A.
    VACCINE, 2019, 37 (36) : 5161 - 5170
  • [37] Evaluation of correlates of protection against influenza A(H3N2) and A (H1N1)pdm09 infection: Applications to the hospitalized patient population
    Petrie, Joshua G.
    Martin, Emily T.
    Truscon, Rachel
    Johnson, Emileigh
    Cheng, Caroline K.
    McSpadden, E. J.
    Malosh, Ryan E.
    Lauring, Adam S.
    Lamerato, Lois E.
    Eichelberger, Maryna C.
    Ferdinands, Jill M.
    Monto, Arnold S.
    VACCINE, 2019, 37 (10) : 1284 - 1292
  • [38] Predicting Influenza H3N2 Vaccine Efficacy From Evolution of the Dominant Epitope
    Bonomo, Melia E.
    Deem, Michael W.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (07) : 1129 - 1131
  • [39] Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist
    Fox, Annette
    Sanchez-Ovando, Stephany
    Carolan, Louise
    Hadiprodjo, A. Jessica
    Chen, Yuyun
    Ho, Faith
    Cheng, Samuel M. S.
    Thompson, Mark G.
    Iuliano, A. Danielle
    Levine, Min Z.
    Valkenburg, Sophie A.
    Ip, Dennis K. M.
    Peiris, J. S. Malik
    Sullivan, Sheena G.
    Cowling, Benjamin J.
    Leung, Nancy H. L.
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [40] Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018-2019
    Glatman-Freedman, Aharona
    Pando, Rakefet
    Sefty, Hanna
    Omer, Itay
    Rosenberg, Alina
    Drori, Yaron
    Nemet, Ital
    Mendelson, Ella
    Keinan-Boker, Lital
    Mandelboim, Michal
    VACCINES, 2020, 8 (01)